145 related articles for article (PubMed ID: 8572666)
21. Two mechanisms of antigen-specific apoptosis of myelin basic protein (MBP)-specific T lymphocytes derived from multiple sclerosis patients and normal individuals.
Pelfrey CM; Tranquill LR; Boehme SA; McFarland HF; Lenardo MJ
J Immunol; 1995 Jun; 154(11):6191-202. PubMed ID: 7538545
[TBL] [Abstract][Full Text] [Related]
22. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
Jung EJ; Hur M; Kim YL; Lee GH; Kim J; Kim I; Lee M; Han HK; Kim MS; Hwang S; Kim S; Woo AM; Yoon Y; Park HJ; Won J
J Pharmacol Exp Ther; 2009 Dec; 331(3):1005-13. PubMed ID: 19741152
[TBL] [Abstract][Full Text] [Related]
23. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG
Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538
[TBL] [Abstract][Full Text] [Related]
24. Antigen therapy of experimental autoimmune encephalomyelitis selectively induces apoptosis of pathogenic T cells.
Tischner D; Weishaupt A; van den Brandt J; Ip CW; Kerkau T; Gold R; Reichardt HM
J Neuroimmunol; 2007 Feb; 183(1-2):146-50. PubMed ID: 17198735
[TBL] [Abstract][Full Text] [Related]
25. Cellular and molecular aspects of the pathomechanism and therapy of murine experimental allergic encephalomyelitis.
Tabira T
Crit Rev Neurobiol; 1989; 5(2):113-42. PubMed ID: 2484301
[TBL] [Abstract][Full Text] [Related]
26. Demyelination induced by T cell lines and clones specific for myelin basic protein in mice.
Tabira T; Sakai K
Lab Invest; 1987 May; 56(5):518-25. PubMed ID: 2437389
[TBL] [Abstract][Full Text] [Related]
27. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1.
Johns LD; Flanders KC; Ranges GE; Sriram S
J Immunol; 1991 Sep; 147(6):1792-6. PubMed ID: 1716279
[TBL] [Abstract][Full Text] [Related]
28. [Experimental allergic encephalomyelitis as a model for the study of therapeutic concepts for encephalomyelitis disseminata].
Meyer-Rienecker HJ; Günther J; Gundlach HJ; Schröter P; Hitzchke B
Psychiatr Neurol Med Psychol (Leipz); 1975 Dec; 27(12):725-36. PubMed ID: 59933
[TBL] [Abstract][Full Text] [Related]
29. [Therapeutic effect of myelin basic protein and synthetic encephalitogenic peptide in guinea pigs with experimental allergic encephalomyelitis].
Belik IaV; Terletskaia IaT; Kozulina EP; Syrovatskaia LP; Gershkovich AA
Vopr Med Khim; 1978; 24(3):372-7. PubMed ID: 78577
[TBL] [Abstract][Full Text] [Related]
30. Modulation of experimental allergic encephalomyelitis with anti-T suppressor factor antibodies.
Perry LL; Barzaga ME; Ferguson TA
J Immunol; 1988 Nov; 141(9):3016-21. PubMed ID: 2902141
[TBL] [Abstract][Full Text] [Related]
31. Has myelin basic protein received a fair trial in the treatment of multiple sclerosis?
Alvord EC; Shaw CM; Hruby S; Kies MW
Ann Neurol; 1979 Dec; 6(6):461-8. PubMed ID: 93873
[TBL] [Abstract][Full Text] [Related]
32. [Immune response against myelin basic protein and analysis of T-cell receptor in multiple sclerosis].
Usuku K
Nihon Rinsho; 1994 Nov; 52(11):2932-9. PubMed ID: 7527866
[TBL] [Abstract][Full Text] [Related]
33. Adoptively transferred chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Neuropathologic analysis.
Raine CS; Mokhtarian F; McFarlin DE
Lab Invest; 1984 Nov; 51(5):534-46. PubMed ID: 6208409
[TBL] [Abstract][Full Text] [Related]
34. MS: a localized immune disease of the central nervous system.
Calder V; Owen S; Watson C; Feldmann M; Davison A
Immunol Today; 1989 Mar; 10(3):99-103. PubMed ID: 2472812
[TBL] [Abstract][Full Text] [Related]
35. [Experimental autoimmune encephalomyelitis: immunoregulation and genetic control].
Bernard D; Beraud E; Varriale S; Golstein MM
Pathol Biol (Paris); 1987 Mar; 35(3):285-9. PubMed ID: 2954020
[TBL] [Abstract][Full Text] [Related]
36. Conclusion: is myelin basic protein the right antigen and experimental allergic encephalomyelitis the right model for multiple sclerosis?
Alvord EC
Prog Clin Biol Res; 1984; 146():503-8. PubMed ID: 6201920
[No Abstract] [Full Text] [Related]
37. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis.
Critchfield JM; Racke MK; Zúñiga-Pflücker JC; Cannella B; Raine CS; Goverman J; Lenardo MJ
Science; 1994 Feb; 263(5150):1139-43. PubMed ID: 7509084
[TBL] [Abstract][Full Text] [Related]
38. Effect of diphenyl diselenide on the development of experimental autoimmune encephalomyelitis.
Chanaday NL; de Bem AF; Roth GA
Neurochem Int; 2011 Dec; 59(8):1155-62. PubMed ID: 22032971
[TBL] [Abstract][Full Text] [Related]
39. Chronic relapsing experimental autoimmune encephalomyelitis. Ultrastructure of the central nervous system of animals treated with combinations of myelin components.
Raine CS; Traugott U
Lab Invest; 1983 Mar; 48(3):275-84. PubMed ID: 6186840
[TBL] [Abstract][Full Text] [Related]
40. Immunospecific therapy of central nervous system autoaggression with an antigen-specific T cell line.
Wekerle H
Prog Clin Biol Res; 1984; 146():435-41. PubMed ID: 6201913
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
